Inhibition of DNA synthesis by RB: Effects on G1/S transition and S- phase progression

Genes and Development

Volumn 12, Issue 15, 1998, Pages 2278-2292

  Knudsen, Erik S ^a,b   Buckmaster, Carolan ^a,b   Chen, Tung Ti ^a   Feramisco, James R ^a,b   Wang, Jean Y J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cyclin A; Cyclin E; p16ink4a; p21cip1; T antigen

Indexed keywords

RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA REPLICATION; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0032146267     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.15.2278     Document Type: Article

References (55)

1. Akiyama, T., T. Ohuchi, S. Sumida, K. Matsumoto, and K. Toyoshima. 1992. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. 89: 7900-7904.
2. Alevizopoulos, K., J. Vlach, S. Hennecke, and B. Amati. 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16: 5322-5333.
3. Bartek, J., J. Bartkova, and J. Lukas. 1997. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237: 1-6.
4. Beijersbergen, R.L. and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitor proteins. Biochim. Biophys. Acta. 1287: 103-120.
5. Brehm, A., E.A. Miska, D.J. McCance, J.L. Reid, A.J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
6. Capecchi, M.R. 1980. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 2: 479-488.
7. Chen, P.L., P. Scully, J.Y. Shew, J.Y.J. Wang, and W.H. Lee. 1988. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198.
8. Chen, Y., E.S. Knudsen, and J.Y.J. Wang. 1996. Cells arrested in G1 by the v-Abl tyrosine kinase do not express cyclin A despite the hyperphosphorylation of RB. J. Biol. Chem. 271: 19637-19640.
9. Connell-Crowley, L., J.W. Harper, and D.W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8: 287-301.
10. DeCaprio, J.A., J.W. Ludlow, J. Figge, J.Y. Shew, C.M. Huang, W.H. Lee, E. Marsilio, E. Paucha, and D.M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283.
11. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
12. 1 restriction point. Grit. Rev. Oncogenesis 7: 127-142.
13. Geng, Y., E.N. Eaton, M. Picón, J.M. Roberts, A.S. Lundberg, A. Gifford, C. Sardet, and R.A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180.
14. Gill, R.M., P.A. Hamel, J. Zhe, E. Zacksenhaus, B.L. Gallie, and R.A. Phillips. 1994. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ. 5: 467-474.
15. Goodrich, D.W., N.P. Wang, Y.W. Qian, E.Y.H.P. Lee, and W.H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293-302.
16. Hamel, P.A., R.M. Gill, R.A. Phillips, and B.L. Gallie. 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7: 693-701.
17. Hamel, P.A., R.A. Phillips, M. Muncaster, and B.L. Gallie. 1993. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 7: 846-854.
18. Herrera, R.E., T.P. Mäkelä, and R.A. Weinberg. 1996a. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7: 1335-1342.
19. Herrera, R.E., V.P. Sah, B.O. Williams, T.P. Mäkelä, R.A. Weinberg, and T. Jacks. 1996b. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16: 2402-2407.
20. Huang, L.C., K.C. Clarkin, and G.M. Wahl. 1996. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc. Natl. Acad. Sci. 93: 4827-4832.
21. Hunter, T. and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
22. Hurford, R.K., Jr., D. Cobrinik, M.H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes & Dev. 11: 1447-1463.
23. Kaelin, W.G., Jr. 1997. Recent insights into the functions of the retinoblastoma susceptibility gene product. Cancer Invest. 15: 243-254.
24. Knudsen, E.S. and J.Y.J. Wang. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271: 8313-8320.
25. _ 1997. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17: 5771-5783.
26. Koh, J., G.H. Enders, B.D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510.
27. Kowalik, T.F., J. DeGregori, J.K. Schwarz, and J.R. Nevins. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69: 2491-2500.
28. Lees, J.A., K.J. Buchkovich, D.R. Marshak, C.W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10: 4279-4290.
29. Lin, B.T., S. Gruenwald, A.O. Morla, W.H. Lee, and J.Y.J. Wang. 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10: 857-864.
30. Lukas, J., D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503-506.
31. Lukas, J., T. Herzinger, K. Hansen, M.C. Moroni, D. Resnitzky, K. Helin, S.I. Reed, and J. Bartek. 1997. Cyclin E-induced S-phase without activation of the pRb/E2F pathway. Genes & Dev. 11: 1479-1492.
32. Lundberg, A.S. and R.A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18: 753-701.
33. Luo, R.X., A.A. Postigo, and D.C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473.
34. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J.P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605.
35. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
36. Medema, R.H., R.E. Herrera, F. Lam, and R.A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. 92: 6289-6293.
37. Meyerson, M. and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077-2086.
38. Ohtani, K., J. DeGregori, and J.R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. 92: 12146-12150.
39. Ohtani, K., J. DeGregori, G. Leone, D.R. Herendeen, T.J. Kelly, and J.R. Nevins. 1996. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell. Biol. 16: 6977-6984.
40. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11: 961-971.
41. Palmero, I. and G. Peters. 1996. Perturbation of cell cycle regulators in human cancer. Cancer Surv. 27: 351-367.
42. Qin, X.Q., T. Chittenden, D.M. Livingston, and W.G. Kaelin, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes & Dev. 6: 953-964.
43. Qin, X.Q., D.M. Livingston, W.G. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
44. Resnitzky, D. and S.I. Reed. 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15: 3463-3469.
45. Resnitzky, D., L. Hengst, and S.I. Reed. 1995. Cyclin A-associated kinase activity is rate limiting for entrance into S-phase and is negatively regulated in G1 by p27Kip1. Mol. Cell. Biol. 15: 4347-4352.
46. Shan, B. and W.H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166-8173.
47. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
48. Sidle, A., C. Palaty, P. Dirks, O. Wiggan, M. Kiess, R.M. Gill, A.K. Wong, and P.A. Hamel. 1996. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol. 31:237-271.
49. Slansky, J.E. and P.J. Farnham. 1996. Introduction to the E2F family: Protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-30.
50. Strausfeld, U.P., M. Howell, R. Rempel, J.L. Maller, T. Hunt, and J.J. Blow. 1994. Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr. Biol. 4: 876-883.
51. Wang, J.Y.J., E.S. Knudsen, and P.J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64: 25-85.
52. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
53. Welch, P.J. and J.Y.J. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790.
54. Zalvide, J., H. Stubdal, and J.A. DeCaprio. 1998. The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol Cell. Biol. 18: 1408-1415.
55. Zarkowska, T. and S. Mittnacht. 1997. Differential phosphorylation of the retinoblastoma protein by G(2)/S cyclin-dependent kinases. J. Biol. Chem. 272: 12738-12746.